20
Jul 2026
Announcing a new article publication for Zoonoses journal. This study was aimed at conducting a systematic review and meta-analysis of antimicrobial resistance patterns and treatment outcomes of S. suis infections in Southeast Asia, where this zoonotic pathogen poses a major public health concern through consumption of raw or undercooked pork.
20
Jul 2026
Findings from Bonn, Edinburgh and Newcastle could give a boost to pharmaceutical research.
20
Jul 2026
Metabolic phenotyping enables rapid detection of viral infections within minutes by identifying early biochemical changes in the body.
20
Jul 2026
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Low consumption of fruits and vegetables (FV) is a major preventable contributor to cardiovascular disease (CVD).
20
Jul 2026
The buildup of fats, cholesterol, calcium, and immune cells within the blood vessel can lead to the narrowing or even complete blockage of the blood vessel.
20
Jul 2026
Researchers have built a tool to uncover hidden issues in the massive datasets used to train medical AI.
20
Jul 2026
hVIVO explains how ddPCR and NGS support viral surveillance in antiviral trials, from detection and quantification to resistance sequencing.
20
Jul 2026
Researchers have found that with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should use different criteria for identifying patients with poor odds of survival.
20
Jul 2026
Previous studies have found that caffeine is the world's most popular stimulant and psychoactive substance, and coffee is the most common way people consume caffeine.
20
Jul 2026
Researchers at EMBL Hamburg and collaborators at the Leibniz Research Institute for Molecular Pharmacology (FMP) have mapped how the influenza A virus rewires infected human cells in unprecedented detail.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
